Severe Progressive Mycobacterium avium Complex Infection Associated With Brentuximab Vedotin Therapy

J Pediatric Infect Dis Soc. 2019 Sep 25;8(4):371-373. doi: 10.1093/jpids/piy109.
No abstract available

Keywords: Mycobacterium avium complex; Hodgkin disease; brentuximab vedotin; immunoconjugates.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Animals
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Brentuximab Vedotin / adverse effects*
  • Brentuximab Vedotin / therapeutic use
  • CD30 Ligand / genetics
  • CD30 Ligand / metabolism
  • Disease Models, Animal
  • Drug Therapy
  • Female
  • Hodgkin Disease / complications*
  • Hodgkin Disease / diagnostic imaging
  • Hodgkin Disease / drug therapy
  • Hodgkin Disease / pathology
  • Humans
  • Immunoconjugates / adverse effects
  • Immunoconjugates / immunology
  • Lung / pathology
  • Mice
  • Mycobacterium avium Complex / pathogenicity*
  • Mycobacterium avium-intracellulare Infection / complications*
  • Mycobacterium avium-intracellulare Infection / microbiology
  • Mycobacterium avium-intracellulare Infection / pathology

Substances

  • Antineoplastic Agents
  • CD30 Ligand
  • Immunoconjugates
  • TNFSF8 protein, human
  • Brentuximab Vedotin